Page 14 - System Atrophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from System Atrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In System Atrophy Today - Breaking & Trending Today

Appendix 4C - Q2 FY22 Quarterly Cash Flow Report

Published: January 27, 2022

Highlights: MELBOURNE, Australia, Jan. 27, 2022 /PRNewswire/ -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 31st December 2021 (Q2 FY22). The Company's cash position on...

Source: asiaone.com

Appendix 4C - Q2 FY22 Quarterly Cash Flow Report

Published: January 27, 2022

Highlights: NZ’s regulator Medsafe authorizes Phase 2 clinical trial for ATH434; more jurisdictions to follow New poster presentation and publications...

Source: fnarena.com

Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Published: December 15, 2021

Initiation of Phase 2 Clinical Trial Expected in CY Q1 2022 MELBOURNE, Australia, Dec. 14, 2021 /PRNewswire/ — Alterity Therapeutics (ASX:...

Source: fnarena.com

Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Published: December 14, 2021

/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying...

Source: prnewswire.com